LGENIA and Harvard join as collaborators of the Gates Foundation’s TB Drug Accelerator

Lgenia and Harvard join Gates Foundation’s TB Accelerator team

At the spring 2018 meeting of the Bill and Melinda Gates Foundation’s TB Drug Accelerator, two new institutions were elected as full member collaborators – Harvard University and LGENIA! We now join 20 other member organizations in this important mission, and we are proud to be the first biotechnology company on their team.